Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Impact of Diabetes on the Lungs
Higher HbA1c Levels Increase the Risk of Cellulitis
Is Empagliflozin Safe and Effective for Patients with HFrEF and Low Blood Pressure?
Metformin or Sulfonylurea Use Significantly Lowered Risk of Mortality for COVID-19 Patients with T2D
Letter from the Editor
We know that there are many complications associated with diabetes, and the longer you have diabetes, the more likely these comorbidities will develop and worsen. One group of complications that often gets overlooked is respiratory dysfunctions.
This week our intern Andy Dao, PharmD Candidate, University of South Florida Taneja College of Pharmacy, looks to see if long term patients with controlled A1c’s have better long term respiratory function.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES — Diabetes News and Research
New research suggests that A1c may play a more prominent role than the duration of diabetes when it comes to respiratory function.
Is current evidence supportive of metformin as an adjunct therapy for pregnant women with diabetes?
Patients with diabetes who have worse glucose control may have a higher risk of infections.
The interaction between systolic blood pressure (SBP) and the effects of empagliflozin in patients with heart failure with reduced ejection fraction (HFrEF).
Metformin or Sulfonylurea Use Significantly Lowered Risk of Mortality for COVID-19 Patients with T2D
Insulin is not recommended for COVID-19 patients with T2D due to increased mortality risk,
Dapagliflozin is well studied in type 2 diabetes mellitus and HF and CKD patients with positive results and a good safety profile.
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this newsletter:
Grace Behr, PharmD/MBA Candidate, Creighton University
Andy Dao, PharmD Candidate, University of South Florida Taneja College of Pharmacy
Alexis Dunn, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences
Kornelia Ilias, Creighton University | School of Pharmacy and Health Professions Doctor of Pharmacy Candidate Class of 2022
Ding Nguyen, PharmD Candidate, University of South Florida Taneja College of Pharmacy
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com